Skip to main content
. Author manuscript; available in PMC: 2017 Aug 17.
Published in final edited form as: Osteoporos Int. 2016 Jun 24;27(12):3485–3494. doi: 10.1007/s00198-016-3675-7

Fig. 1. Association of high bone turnover (Q4) with greater periosteal expansion at the femoral neck minimum CSA (Q4=0.12 to 9.66%) in men.

Fig. 1

OR (95% CI) are adjusted for age (Model 1), and then for BMI, smoking, alcohol consumption, physical activity level, mobility disability, serum 25OHD, PTH, follow-up duration, DM, Oral glucocorticoid or antiepileptic drugs, and anti-bone loss drug (Model 2).

Bars indicate 95% confidence intervals. Dotted line, null value (OR = 1.0).